Reduced doses of emicizumab achieve good efficacy: Results from a national-wide multicentre real-world study in China.
Xu Y, Wang Y, Wu R, Zheng C, Zhang L, Xu W, Feng X, Wang H, Cao X, He L, Xue T, Jin M, Xie B, Ling J, Sun L, Su R, Cheng H, Fang Y, Poon MC, Liu W, Zhang L, Xue F, Yang R.
Xu Y, et al. Among authors: feng x.
Haemophilia. 2024 Jun 9. doi: 10.1111/hae.15062. Online ahead of print.
Haemophilia. 2024.
PMID: 38853005